These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18365653)

  • 1. Drug targets in kinetoplastid parasites. Preface.
    Majumder HK
    Adv Exp Med Biol; 2008; 625():vii-viii. PubMed ID: 18365653
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetoplast as a potential chemotherapeutic target of trypanosomatids.
    Motta MC
    Curr Pharm Des; 2008; 14(9):847-54. PubMed ID: 18473834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in identifying and validating drug targets in trypanosomes and leishmanias.
    Barrett MP; Mottram JC; Coombs GH
    Trends Microbiol; 1999 Feb; 7(2):82-8. PubMed ID: 10081086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs affecting trypanosome topoisomerases.
    Shapiro TA
    Adv Pharmacol; 1994; 29B():187-200. PubMed ID: 8996608
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective lead compounds against kinetoplastid tubulin.
    Morgan RE; Werbovetz KA
    Adv Exp Med Biol; 2008; 625():33-47. PubMed ID: 18365657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA topoisomerases of Leishmania: the potential targets for anti-leishmanial therapy.
    Das BB; Ganguly A; Majumder HK
    Adv Exp Med Biol; 2008; 625():103-15. PubMed ID: 18365662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scaffold proteins LACK and TRACK as potential drug targets in kinetoplastid parasites: Development of inhibitors.
    Qvit N; Schechtman D; Pena DA; Berti DA; Soares CO; Miao Q; Liang LA; Baron LA; Teh-Poot C; Martínez-Vega P; Ramirez-Sierra MJ; Churchill E; Cunningham AD; Malkovskiy AV; Federspiel NA; Gozzo FC; Torrecilhas AC; Manso Alves MJ; Jardim A; Momar N; Dumonteil E; Mochly-Rosen D
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):74-84. PubMed ID: 27054066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique characteristics of the kinetoplast DNA replication machinery provide potential drug targets in trypanosomatids.
    Sela D; Milman N; Kapeller I; Zick A; Bezalel R; Yaffe N; Shlomai J
    Adv Exp Med Biol; 2008; 625():9-21. PubMed ID: 18365655
    [No Abstract]   [Full Text] [Related]  

  • 9. Susceptibility of dyskinetoplastic Trypanosoma evansi and T. equiperdum to isometamidium chloride.
    Kaminsky R; Schmid C; Lun ZR
    Parasitol Res; 1997; 83(8):816-8. PubMed ID: 9342750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venturicidin A affects the mitochondrial membrane potential and induces kDNA loss in
    Hauser DA; Kaiser M; Mäser P; Albisetti A
    Antimicrob Agents Chemother; 2024 Jul; 68(7):e0167123. PubMed ID: 38869301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavable complex formation in Leishmania chagasi treated with anilinoacridines.
    Werbovetz KA; Spoors PG; Pearson RD; Macdonald TL
    Mol Biochem Parasitol; 1994 May; 65(1):1-10. PubMed ID: 7935616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular trafficking in trypanosomatids: a new target for therapies?
    Costa-Pinto D; Trindade LS; McMahon-Pratt D; Traub-Cseko YM
    Int J Parasitol; 2001 May; 31(5-6):536-43. PubMed ID: 11334939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pentose Phosphate Pathway in Parasitic Trypanosomatids.
    Kovářová J; Barrett MP
    Trends Parasitol; 2016 Aug; 32(8):622-634. PubMed ID: 27174163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fellowship of the rings: the replication of kinetoplast DNA.
    Liu B; Liu Y; Motyka SA; Agbo EE; Englund PT
    Trends Parasitol; 2005 Aug; 21(8):363-9. PubMed ID: 15967722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetoplast DNA minicircle binding proteins in a Leishmania Spp: interference of protein DNA interaction by berenil.
    Singh R; Siddiqui KA; Valenzuela MS; Majumder HK
    Indian J Biochem Biophys; 1995 Dec; 32(6):437-41. PubMed ID: 8714215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fishing for anti-leishmania drugs: principles and problems.
    Handman E; Kedzierski L; Uboldi AD; Goding JW
    Adv Exp Med Biol; 2008; 625():48-60. PubMed ID: 18365658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parasitology. Drugs to combat tropical protozoan parasites.
    Gelb MH; Hol WG
    Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
    [No Abstract]   [Full Text] [Related]  

  • 18. Phenyl substitution of furamidine markedly potentiates its anti-parasitic activity against Trypanosoma cruzi and Leishmania amazonensis.
    De Souza EM; Lansiaux A; Bailly C; Wilson WD; Hu Q; Boykin DW; Batista MM; Araújo-Jorge TC; Soeiro MN
    Biochem Pharmacol; 2004 Aug; 68(4):593-600. PubMed ID: 15276066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Strong Anti-Kinetoplastid Properties of Bee Propolis: Composition and Identification of the Active Agents and Their Biochemical Targets.
    Ebiloma GU; Ichoron N; Siheri W; Watson DG; Igoli JO; De Koning HP
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33167520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neglected tropical diseases: multi-target-directed ligands in the search for novel lead candidates against Trypanosoma and Leishmania.
    Cavalli A; Bolognesi ML
    J Med Chem; 2009 Dec; 52(23):7339-59. PubMed ID: 19606868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.